Cetera Investment Advisers’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $20.9M | Sell |
378,190
-84,251
| -18% | -$4.57M | 0.02% | 659 |
|
|
2025
Q4 | $22.7M | Sell |
462,441
-17,741
| -4% | -$827K | 0.02% | 617 |
|
|
2025
Q3 | $20.7M | Buy |
480,182
+111,726
| +30% | +$4.36M | 0.02% | 630 |
|
|
2025
Q2 | $14.1M | Buy |
368,456
+81,909
| +29% | +$3.13M | 0.02% | 654 |
|
|
2025
Q1 | $11.1M | Buy |
286,547
+23,948
| +9% | +$877K | 0.02% | 717 |
|
|
2024
Q4 | $8.88M | Sell |
262,599
-9,739
| -4% | -$351K | 0.02% | 760 |
|
|
2024
Q3 | $11.1M | Sell |
272,338
-8,985
| -3% | -$368K | 0.02% | 659 |
|
|
2024
Q2 | $10.8M | Buy |
281,323
+155
| +0.1% | +$6.52K | 0.02% | 642 |
|
|
2024
Q1 | $12.1M | Buy |
281,168
+210,971
| +301% | +$8.7M | 0.03% | 598 |
|
|
2023
Q4 | $2.6M | Sell |
70,197
-16,590
| -19% | -$596K | 0.02% | 682 |
|
|
2023
Q3 | $3.15M | Buy |
86,787
+10,489
| +14% | +$372K | 0.03% | 578 |
|
|
2023
Q2 | $2.72M | Buy |
76,298
+883
| +1% | +$31.7K | 0.02% | 641 |
|
|
2023
Q1 | $2.68M | Buy |
75,415
+11,403
| +18% | +$399K | 0.02% | 624 |
|
|
2022
Q4 | $2.25M | Buy |
64,012
+14,651
| +30% | +$488K | 0.02% | 660 |
|
|
2022
Q3 | $1.45M | Buy |
49,361
+3,038
| +7% | +$115K | 0.03% | 568 |
|
|
2022
Q2 | $2.52M | Sell |
46,323
-4,070
| -8% | -$225K | 0.04% | 449 |
|
|
2022
Q1 | $2.74M | Buy |
50,393
+1,163
| +2% | +$63.2K | 0.04% | 453 |
|
|
2021
Q4 | $2.71M | Buy |
49,230
+15,104
| +44% | +$786K | 0.04% | 454 |
|
|
2021
Q3 | $1.63M | Buy |
34,126
+1,624
| +5% | +$81.6K | 0.03% | 594 |
|
|
2021
Q2 | $1.62M | Buy |
32,502
+3,883
| +14% | +$187K | 0.03% | 592 |
|
|
2021
Q1 | $1.28M | Buy |
28,619
+1,420
| +5% | +$64.5K | 0.03% | 569 |
|
|
2020
Q4 | $1.25M | Buy |
27,199
+16,888
| +164% | +$776K | 0.02% | 593 |
|
|
2020
Q3 | $485K | Sell |
10,311
-463
| -4% | -$23.2K | 0.04% | 388 |
|
|
2020
Q2 | $549K | Buy |
10,774
+863
| +9% | +$44.3K | 0.05% | 336 |
|
|
2020
Q1 | $469K | Sell |
9,911
-353
| -3% | -$18.8K | 0.06% | 315 |
|
|
2019
Q4 | $605K | Sell |
10,264
-204
| -2% | -$11.3K | 0.06% | 302 |
|
|
2019
Q3 | $557K | Buy |
10,468
+878
| +9% | +$45.2K | 0.07% | 287 |
|
|
2019
Q2 | $480K | Sell |
9,590
-1,129
| -11% | -$56.7K | 0.06% | 301 |
|
|
2019
Q1 | $558K | Sell |
10,719
-105
| -1% | -$5.25K | 0.08% | 252 |
|
|
2018
Q4 | $520K | Sell |
10,824
-1,802
| -14% | -$88.7K | 0.08% | 240 |
|
|
2018
Q3 | $632K | Buy |
12,626
+781
| +7% | +$39.7K | 0.09% | 232 |
|
|
2018
Q2 | $593K | Buy |
11,845
+347
| +3% | +$17.5K | 0.1% | 217 |
|
|
2018
Q1 | $566K | Sell |
11,498
-1,300
| -10% | -$60.5K | 0.11% | 214 |
|
|
2017
Q4 | $564K | Sell |
12,798
-3,051
| -19% | -$141K | 0.1% | 223 |
|
|
2017
Q3 | $798K | Sell |
15,849
-4,931
| -24% | -$250K | 0.18% | 163 |
|
|
2017
Q2 | $1.11M | Buy |
20,780
+1,469
| +8% | +$78.3K | 0.27% | 103 |
|
|
2017
Q1 | $1.01M | Sell |
19,311
-2,116
| -10% | -$107K | 0.28% | 103 |
|
|
2016
Q4 | $1.04M | Buy |
21,427
+8,650
| +68% | +$427K | 0.35% | 85 |
|
|
2016
Q3 | $686K | Buy |
12,777
+1,397
| +12% | +$76.6K | 0.29% | 98 |
|
|
2016
Q2 | $616K | Buy |
11,380
+1,194
| +12% | +$62.9K | 0.24% | 122 |
|
|
2016
Q1 | $517K | Buy |
10,186
+2,100
| +26% | +$105K | 0.22% | 128 |
|
|
2015
Q4 | $407K | Buy |
+8,086
| New | +$412K | 0.19% | 145 |
|
Other funds holding GSK
JEST
